Neuropsychiatry of the basal ganglia
暂无分享,去创建一个
[1] A. Tröster,et al. Risk factors for dementia in Parkinson's disease: effect of education. , 1996, Neuroepidemiology.
[2] S. Folstein,et al. The association of affective disorder with Huntington's Disease in a case series and in families , 1983, Psychological Medicine.
[3] G. Sawle,et al. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. , 1992, Advances in neurology.
[4] R. Robinson,et al. Depression in neurologic disease , 1993 .
[5] John L Bradshaw,et al. Frontostriatal deficits in unipolar major depression , 1998, Brain Research Bulletin.
[6] Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. , 1999, The New England journal of medicine.
[7] G Bernardi,et al. Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.
[8] K. Marder,et al. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. , 2001, The American journal of psychiatry.
[9] S. Folstein,et al. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.
[10] P. Bräunig,et al. Prevalence of obsessive–compulsive disorder in schizophrenia and significance of motor symptoms , 2002, European Psychiatry.
[11] R G Robinson,et al. Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.
[12] J. Cummings,et al. Obsessive-compulsive disorder in Huntington's disease , 1992, Biological Psychiatry.
[13] P. König. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis , 1989, Biological Psychiatry.
[14] E. Bullmore,et al. Society for Neuroscience Abstracts , 1997 .
[15] A. Lees,et al. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.
[16] R. Albin,et al. Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome , 1999, Neurology.
[17] H. Mayberg,et al. Cognitive impairments and depression in Parkinson's disease: a follow up study. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[18] Holly Moore,et al. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia , 1999, Biological Psychiatry.
[19] J C Rothwell,et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. , 1998, Brain : a journal of neurology.
[20] M. Cooper,et al. Basal ganglia regional glucose metabolism asymmetry during a catatonic episode , 1989, Biological Psychiatry.
[21] A J Lees,et al. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. , 1987, Brain : a journal of neurology.
[22] A. Rosenblatt,et al. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. , 2000, Psychosomatics.
[23] M. Trimble,et al. Electroconvulsive therapy in Parkinson's disease and other movement disorders , 1991, Movement disorders : official journal of the Movement Disorder Society.
[24] M. Kimura,et al. Neuronal activity in the basal ganglia. Functional implications. , 1997, Advances in neurology.
[25] D. Joel,et al. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum , 2000, Neuroscience.
[26] L. Golbe,et al. Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.
[27] T. Robbins,et al. Associative Processes in Addiction and Reward The Role of Amygdala‐Ventral Striatal Subsystems , 1999, Annals of the New York Academy of Sciences.
[28] R. Kerwin,et al. Schizophrenia, psychosis, and the basal ganglia. , 1997, The Psychiatric clinics of North America.
[29] G. E. Alexander,et al. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.
[30] K. Hugdahl,et al. Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[31] G. Comi,et al. Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study , 2002, Biological Psychiatry.
[32] Joseph B. Martin. Huntington's disease , 1984, Neurology.
[33] D. Sax,et al. Increased rate of suicide among patients with Huntington's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[34] C. Goetz,et al. Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.
[35] E. Smeraldi,et al. Increased right caudate nucleus size in obsessive-compulsive disorder: Detection with magnetic resonance imaging , 1992, Psychiatry Research: Neuroimaging.
[36] H. Mayberg,et al. Depression in Parkinson's disease: a biochemical and organic viewpoint. , 1995, Advances in neurology.
[37] B. Knowlton,et al. Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.
[38] M Ashtari,et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. , 1995, Archives of general psychiatry.
[39] S. Rauch,et al. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. , 1997, The Psychiatric clinics of North America.
[40] D. Senitz,et al. Increased volume of the nucleus accumbens in schizophrenia , 2001, Journal of Neural Transmission.
[41] S. Folstein,et al. Huntington disease in Maryland: clinical aspects of racial variation. , 1987, American journal of human genetics.
[42] Scott T. Grafton,et al. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. , 1992, Archives of general psychiatry.
[43] A. Tröster,et al. Unilateral pallidal stimulation for Parkinson's disease: Neurobehavioral functioning before and 3 months after electrode implantation , 1997, Neurology.
[44] Douglas L. Jones,et al. From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.
[45] C. McDougle,et al. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. , 1995, The American journal of psychiatry.
[46] S. Kapur,et al. Serotonin-dopamine interaction and its relevance to schizophrenia. , 1996, The American journal of psychiatry.
[47] H. Allain,et al. Depression in Parkinson's disease , 2000, BMJ : British Medical Journal.
[48] T. Nakajima,et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. , 1997, American journal of human genetics.
[49] J. Stessman,et al. Cognitive disturbances in Parkinsonian patients with depression , 1993 .
[50] Garrett E. Alexander. Basal ganglia , 1998 .
[51] T. Yen. Hepadnaviral X Protein:Review of Recent Progress. , 1996, Journal of biomedical science.
[52] J. Soares,et al. The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.
[53] L. Henriksen,et al. Striatal dysfunction in attention deficit and hyperkinetic disorder. , 1989, Archives of neurology.
[54] W. Schultz,et al. Changes in reward‐induced brain activation in opiate addicts , 2001, The European journal of neuroscience.
[55] H. Fibiger,et al. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. , 1994, The Journal of pharmacology and experimental therapeutics.
[56] J. Jankovic,et al. Variable expression of Parkinson's disease , 1990, Neurology.
[57] Jeste,et al. Psychoses in Parkinson's Disease. , 1998, Seminars in clinical neuropsychiatry.
[58] M. Nader,et al. Progression of Changes in Dopamine Transporter Binding Site Density as a Result of Cocaine Self-Administration in Rhesus Monkeys , 2001, The Journal of Neuroscience.
[59] K. Donaghue. Autonomic Neuropathy: Diagnosis and Impact on Health in Adolescents with Diabetes , 1998, Hormone Research in Paediatrics.
[60] The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 2000 .
[61] B. Maccarthy,et al. Psychiatric morbidity in patients with Parkinson's disease , 1990, Psychological Medicine.
[62] Andreas Heinz,et al. Tourette's syndrome , 1998, Neurology.
[63] J. R. Baker,et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.
[64] J. Cummings,et al. Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.
[65] Joseph Piven,et al. An MRI study of the basal ganglia in autism , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[66] M E Phelps,et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.
[67] J. Cummings,et al. Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[68] A. Coppen. Depression as a lethal disease: prevention strategies. , 1994, The Journal of clinical psychiatry.
[69] Matthew A. Menza,et al. Parkinson's disease and anxiety: Comorbidity with depression , 1993, Biological Psychiatry.
[70] M. Robertson,et al. Tic disorders: new developments in Tourette syndrome and related disorders. , 1998, Current opinion in neurology.
[71] R. Bornstein,et al. Depression accounts for executive function deficits in obsessive-compulsive disorder. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.
[72] M. Trimble,et al. Dopamine receptor availability in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.
[73] D. Joel,et al. Open interconnected model of basal ganglia‐thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[74] B. Bogerts,et al. The pathomorphology of schizophrenia and mood disorders: similarities and differences , 1999, Schizophrenia Research.
[75] T. Dening,et al. Wilson's disease: A longitudinal study of psychiatric symptoms , 1990, Biological Psychiatry.
[76] C. Frith,et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography , 1997, Psychological Medicine.
[77] J. Saint-Cyr,et al. Parkinson's disease and depression. A critical re-evaluation. , 1986, Brain : a journal of neurology.
[78] J. Cummings,et al. Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.
[79] Organic Psychiatry , 1979, Neurology.
[80] D. Benson,et al. Dementia: A Clinical Approach , 1983 .
[81] T. Bolwig,et al. Crime in Huntington’s disease: a study of registered offences among patients, relatives, and controls , 1998, Journal of neurology, neurosurgery, and psychiatry.
[82] J. Hollerman,et al. Reward prediction in primate basal ganglia and frontal cortex , 1998, Neuropharmacology.
[83] G. Paulson,et al. Dementia in Parkinson's disease. , 1986, Archives of neurology.
[84] J. Jankovic,et al. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[85] O. Suchowersky,et al. Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. , 1997, Archives of neurology.
[86] S Arndt,et al. Regional brain enlargement in autism: a magnetic resonance imaging study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[87] T. Robbins,et al. Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.
[88] G. Sawle,et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[89] K. Marder,et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.
[90] H. Mayberg,et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[91] P. Strick,et al. Basal-ganglia 'projections' to the prefrontal cortex of the primate. , 2002, Cerebral cortex.
[92] Mary M. Robertson,et al. Annotation: Gilles de la Tourette syndrome--an update. , 1994, Journal of child psychology and psychiatry, and allied disciplines.
[93] H. Singer,et al. Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.
[94] A. Parent,et al. Carpenter's Human Neuroanatomy , 1996 .
[95] R. Coursey,et al. Lateral preference and neuropsychological correlates of schizotypy , 1992, Psychiatry Research.
[96] A. Green,et al. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. , 1998, The Journal of nervous and mental disease.
[97] R. Coppola,et al. Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding , 1996, Science.
[98] P. Strick,et al. New concepts about the organization of basal ganglia output. , 1997, Advances in neurology.
[99] M. Robertson,et al. Tourette syndrome, associated conditions and the complexities of treatment. , 2000, Brain : a journal of neurology.
[100] J. Stevens,et al. Kindling of the mesolimbic dopamine system , 1978, Neurology.
[101] C. Tanner. Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.
[102] A. J. Kumar,et al. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. , 1991, The American journal of psychiatry.
[103] J. Joyce,et al. D3 Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics , 1999, Annals of the New York Academy of Sciences.
[104] Johannes Lehtonen,et al. Striatal dopamine transporter density in major depression , 1999, Psychopharmacology.
[105] J. Cummings,et al. Depression in patients with Parkinson's disease , 1999, International journal of geriatric psychiatry.
[106] F. Goodwin. Psychiatric side effects of levodopa in man. , 1971, JAMA.
[107] R Kikinis,et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.
[108] J. Bradshaw,et al. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? , 1999, Clinical psychology review.
[109] E. Wolters,et al. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease , 1996, Neurology.
[110] J. Joyce,et al. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. , 1999, The Journal of pharmacology and experimental therapeutics.
[111] G. Hynd,et al. Attention Deficit- Hyperactivity Disorder and Asymmetry of the Caudate Nucleus , 1993, Journal of child neurology.
[112] D. Chamberlin. The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 1996 .
[113] G. Koob. The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction , 1999, Annals of the New York Academy of Sciences.
[114] JaneR . Taylor,et al. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli , 1999, Psychopharmacology.
[115] W. Drevets. Prefrontal Cortical‐Amygdalar Metabolism in Major Depression , 1999, Annals of the New York Academy of Sciences.
[116] M. Akil,et al. Psychiatric and behavioral abnormalities in Wilson's disease. , 1995, Advances in neurology.
[117] Takashi Hanakawa,et al. Cognitive Slowing in Parkinson's Disease: A Behavioral Evaluation Independent of Motor Slowing , 2002, The Journal of Neuroscience.
[118] P. Strick,et al. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. , 1994, Science.
[119] D H Geschwind,et al. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). , 1999, American journal of human genetics.
[120] I. Hickie,et al. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression , 1995, Biological Psychiatry.
[121] A. Lieberman. Managing the neuropsychiatric symptoms of Parkinson's disease , 1998, Neurology.
[122] Manzar Ashtari,et al. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.
[123] Daniel R. Weinberger,et al. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground , 1995, Schizophrenia Research.
[124] Donald M. Hilty. The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 1995 .
[125] Jane S. Paulsen,et al. Neuropsychiatric aspects of Huntington's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[126] J S Fowler,et al. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. , 2000, Cerebral cortex.
[127] J. Saint-Cyr,et al. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease , 1998, Neurology.
[128] A. Deutch. Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. , 1994, The Journal of clinical psychiatry.
[129] B. Bogerts,et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. , 1999, The Journal of neuropsychiatry and clinical neurosciences.
[130] M. Robertson,et al. Sex of parent transmission effect in Tourette's syndrome , 1997, Neurology.
[131] A. Parent,et al. The current model of basal ganglia organization under scrutiny , 1998, Movement disorders : official journal of the Movement Disorder Society.
[132] A. Graybiel. Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.
[133] M. Kunik,et al. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[134] G. Celesia,et al. Psychosis and other psychiatric manifestations of levodopa therapy. , 1970, Archives of neurology.
[135] J. Cummings,et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[136] A. Lees,et al. The clinical features of 67 patients with clinically definite Steele-Richardson-Olszewski syndrome. , 1992, Behavioural neurology.
[137] W. Honer,et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. , 2001, The American journal of psychiatry.
[138] J. Jankovic,et al. Tourettism and dystonia after subcortical stroke , 2002, Movement disorders : official journal of the Movement Disorder Society.
[139] T. Dening,et al. Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.
[140] D. Mash,et al. Dopamine transport function is elevated in cocaine users , 2002, Journal of neurochemistry.
[141] K. Marder,et al. Antecedent clinical features associated with dementia in Parkinson's disease , 1993, Neurology.
[142] R. Mindham. Psychiatric symptoms in Parkinsonism. , 1970, Journal of neurology, neurosurgery, and psychiatry.
[143] A. E. Taylor,et al. The Neuropsychology of Parkinsons-Disease , 1995, Brain and Cognition.
[144] P. Renshaw,et al. Major depression and the basal ganglia. , 1997, The Psychiatric clinics of North America.
[145] G F Koob,et al. Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.
[146] T. Aziz,et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. , 1998, Brain : a journal of neurology.
[147] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.